1College of Sciences and Health Professions, School of Health Sciences, Cleveland State University, Cleveland, Ohio, USA
2Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
3Department of Biological Sciences, Case Western Reserve University School of Dental Medicine, Cleveland, Ohio, USA.
Corresponding author: Rajeev K. Mehlotra, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Biomedical Research Building, #409A, 2109 Adelbert Rd., Cleveland, OH 44106, USA. E-mail: [email protected].
How to cite this article: Alsabony MN, Mehlotra RK. Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future Infect Microb Dis 2021;00(00):00–00. doi: 10.1097/IM9.0000000000000050
Received 12 November, 2020
Revised 11 December, 2020
Accepted 15 December, 2020
Funding: No funding was received for this work.
Conflict of Interest: The authors reported no conflict of interest.
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0